Amgen · Cash & Short-Term Investments

Latest reported$9.13Bperiod endingDec 31, 2025

AMGN FY Cash & Short-Term Investments ($66.60M → $9.13B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

AMGN cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	9,129,000,000
Dec 31, 2024	11,973,000,000
Dec 31, 2023	10,944,000,000
Dec 31, 2022	9,305,000,000
Dec 31, 2021	8,037,000,000
Dec 31, 2020	10,647,000,000
Dec 31, 2019	8,911,000,000
Dec 31, 2018	29,304,000,000
Dec 31, 2017	41,678,000,000
Dec 31, 2016	38,085,000,000
Dec 31, 2015	31,382,000,000
Dec 31, 2014	27,026,000,000
Dec 31, 2013	19,401,000,000
Dec 31, 2012	24,061,000,000
Dec 31, 2011	20,641,000,000
Dec 31, 2010	17,422,000,000
Dec 31, 2009	13,442,000,000
Dec 31, 2008	9,552,000,000
Dec 31, 2007	7,151,000,000
Dec 31, 2006	6,277,000,000
Dec 31, 2005	5,255,000,000
Dec 31, 2004	5,808,000,000
Dec 31, 2003	5,123,000,000
Dec 31, 2002	4,664,000,000
Dec 31, 2001	2,662,200,000
Dec 31, 2000	2,028,100,000
Dec 31, 1999	1,333,000,000
Dec 31, 1998	201,100,000
Dec 31, 1997	239,100,000
Dec 31, 1996	169,300,000
Dec 31, 1995	66,700,000
Dec 31, 1994	211,300,000
Dec 31, 1993	128,500,000
Dec 31, 1992	92,000,000
Dec 31, 1991	146,500,000
Dec 31, 1990	35,700,000
Mar 31, 1989	20,700,000
Mar 31, 1988	105,600,000
Mar 31, 1987	57,600,000
Mar 31, 1986	66,600,000